Johnson & Johnson Soars on Bullish Analyst Calls and Strong Earnings

# Johnson & Johnson Stock Climbs Near 52-Week High: Analyst Upgrades & Strong Q2 Earnings Boost Investor Confidence In this podcast episode, we break down Johnson & Johnson's (JNJ) impressive stock performance as it trades around $168.11, approaching its yearly high. Learn how JNJ shares have rebounded over 5% since mid-July, supported by significant analyst upgrades from UBS, Barclays, and Morgan Stanley. We analyze the recent Q2 earnings report that exceeded expectations with $23.7 billion in revenue (up 6% year-over-year) and $2.77 EPS, prompting management to raise full-year guidance. Discover why options traders are showing bullish sentiment with high volume in $170 strike calls, and why JNJ's combination of innovation, steady dividends, and below-industry P/E ratio continues to attract investors despite ongoing talc litigation challenges. For healthcare investors seeking growth and income, this episode provides essential insights into one of the market's most enduring blue-chip stocks. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.